# A Study of Epinastine Nasal Spray in Subjects With Seasonal Allergic Rhinitis

> **NCT00407927** · PHASE2 · COMPLETED · sponsor: **Merck Sharp & Dohme LLC** · enrollment: 571 (actual)

## Conditions studied

- Seasonal Allergic Rhinitis

## Interventions

- **DRUG:** Epinastine Nasal Spray

## Key facts

- **NCT ID:** NCT00407927
- **Lead sponsor:** Merck Sharp & Dohme LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-12
- **Primary completion:** 2007-03
- **Final completion:** 2007-03
- **Target enrollment:** 571 (ACTUAL)
- **Last updated:** 2015-10-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00407927

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00407927, "A Study of Epinastine Nasal Spray in Subjects With Seasonal Allergic Rhinitis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00407927. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*